Re: Michael B. Atkins, Elizabeth R. Plimack, Igor Puzanov, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-randomised, Open-label, Dose-finding, and Dose-expansion Phase 1b Trial. Lancet Oncol 2018;19:405 –15

Publication date: Available online 27 April 2018 Source:European Urology Author(s): Vincenzo Di Nunno, Matteo Santoni, Francesco Massari
Source: European Urology - Category: Urology & Nephrology Source Type: research